GO
Loading...

Gilead Sciences Inc

More

  • Midday Glance: Biotechnology companies Friday, 26 Dec 2014 | 1:20 PM ET

    Amgen Inc. rose $2.54 or 1.6 percent, to $163.21. Biogen Idec rose$. 53 or. 2 percent, to $341.41. Celgene Corp. rose $3.29 or 3.0 percent, to $112.89.

  • Most active Nasdaq-traded stocks Friday, 26 Dec 2014 | 1:20 PM ET

    Achillion Pharmaceuticals Inc. fell 2.8 percent to $12.69 with 6,929,000 shares traded. American Realty Capital Properties Inc. fell. 7 percent to $8.28 with 5,611,300 shares traded. Apple Inc. rose 1.3 percent to $113.44 with 12,977,800 shares traded.

  • NEW YORK, Dec 26- U.S. stocks rose on Friday, with major indexes hitting records and on track for a second straight weekly advance, though trading was light with many traders still out for the Christmas holiday. The advance continued Wall Street's recent upward bias, with the S&P up about 6 percent from a recent closing low hit earlier this month.

  • Early Glance: Biotechnology companies Friday, 26 Dec 2014 | 10:23 AM ET

    Amgen Inc. rose $2.52 or 1.6 percent, to $163.19. Biogen Idec rose $1.65 or. 5 percent, to $342.54. Celgene Corp. rose $3.15 or 2.9 percent, to $112.75.

  • NEW YORK, Dec 26- U.S. stocks rose on Friday, with major indexes hitting new records and on track for a second straight weekly advance, though trading was light with many traders still out for the Christmas holiday. The advance continued Wall Street's recent upward bias, with the S&P up about 6 percent from a recent closing low hit earlier this month.

  • *Markets on track for positive week, indexes near records. NEW YORK, Dec 26- U.S. stock index futures pointed to a higher open on Friday, putting major indexes on track for a second straight weekly advance, though moves were likely to be slight with few market catalysts and many traders still out for the Christmas holiday. Wall Street has rallied of late, with both the...

  • Most active Nasdaq-traded stocks Wednesday, 24 Dec 2014 | 6:02 PM ET

    Achillion Pharmaceuticals Inc. rose 10.3 percent to $13.06 with 12,986,900 shares traded. American Realty Capital Properties Inc. was unchanged at $8.33 with 18,528,800 shares traded. Apple Inc. fell. 5 percent to $112.01 with 14,146,700 shares traded.

  • *Initial jobless claims fall for fourth straight week. *Biotech shares rebound after sharp two-day decline; energy falls. NEW YORK, Dec 24- U.S. stocks closed flat in a short session on Wednesday as investors found few reasons to push major indexes to their sixth straight day of gains despite strength in biotechs and bullish labor market data.

  • *Initial jobless claims fall for fourth straight week. *Equity markets close at 1 p.m. in holiday-shortened session. NEW YORK, Dec 24- U.S. stocks edged higher on Wednesday, with the Dow and S&P 500 at records and on track for a sixth straight daily advance as biotech stocks rallied and data pointed to improving economic conditions.

  • Early Glance: Biotechnology companies Wednesday, 24 Dec 2014 | 10:23 AM ET

    Amgen Inc. rose $4.40 or 2.8 percent, to $161.92. Biogen Idec rose $4.11 or 1.2 percent, to $339.87. Celgene Corp. rose $3.71 or 3.5 percent, to $109.83.

  • Final Glance: Biotechnology companies Tuesday, 23 Dec 2014 | 6:06 PM ET

    Amgen Inc. fell $7.01 or 4.3 percent, to $157.52. Biogen Idec fell $16.53 or 4.7 percent, to $335.76. Celgene Corp. fell $7.38 or 6.5 percent, to $106.12.

  • Most active Nasdaq-traded stocks Tuesday, 23 Dec 2014 | 1:22 PM ET

    Achillion Pharmaceuticals Inc. fell 23.6 percent to $11.84 with 28,871,400 shares traded. Apple Inc. fell. 4 percent to $112.54 with 24,723,500 shares traded. Celgene Corp. fell 6.5 percent to $106.12 with 17,637,300 shares traded.

  • Midday Glance: Biotechnology companies Tuesday, 23 Dec 2014 | 1:22 PM ET

    Amgen Inc. fell $9.68 or 5.9 percent, to $154.85. Biogen Idec fell $23.27 or 6.6 percent, to $329.02. Celgene Corp. fell $9.05 or 8.0 percent, to $104.46.

  • LOS ANGELES, Dec 23- Express Scripts, the largest manager of prescription drug plans for U.S. employers, is taking an increasingly aggressive stance in price negotiations with pharmaceutical companies after winning discounts on medications with a strategy introduced last year. On Monday, Express Scripts said it lined up a cheaper price for AbbVie Inc's newly...

  • NEW YORK, Dec 23- U.S. stocks advanced on Tuesday, as the Dow climbed above the 18,000 mark for the first time in history and the S&P 500 set a new intraday record after an unexpectedly strong report on economic growth. The gains pushed the Dow as high as 18,051.14, and the index is now up about 175 percent from a 12- year low hit on March 9, 2009. "What was most interesting...

  • NEW YORK, Dec 23- U.S. stock index futures were little changed on Tuesday, after the Dow and S&P 500 closed at fresh records and ahead of a raft of economic data. *Major Wall Street indexes have risen for four straight sessions, pushing the benchmark S&P index to its 50th record high of the year. The S&P has risen 5.4 percent over that period, its best 4- day run since July...

  • Asian shares up after Dow surpasses 18,000 points Tuesday, 23 Dec 2014 | 4:31 AM ET

    In a year full of market milestones, Wall Street crushed a couple more Tuesday, lifting the Dow Jones industrial average past the 18,000- point mark for the first time and delivering the Standard& Poor's 500 index its second record-high close in two days. Investors welcomed the latest encouraging news on the economy as the government said the U.S. grew at the...

  • LOS ANGELES, Dec 23- Express Scripts, the largest manager of prescription drug plans for U.S. employers, is taking an increasingly aggressive stance in price negotiations with pharmaceutical companies after winning discounts on medications with a strategy introduced last year. On Monday, Express Scripts said it lined up a cheaper price for AbbVie Inc's newly...

  • Final Glance: Biotechnology companies Monday, 22 Dec 2014 | 7:19 PM ET

    Amgen Inc. fell $5.64 or 3.3 percent, to $164.53. Biogen Idec fell $8.38 or 2.3 percent, to $352.29. Celgene Corp. fell $3.68 or 3.1 percent, to $113.50.

  • Cramer Remix: This sector is on fire Monday, 22 Dec 2014 | 7:05 PM ET
    Jim Cramer on Mad Money.

    It’s alive! "Mad Money" host Jim Cramer has the way to play an industry that’s buzzing again.